🟢 Adaptive Biotechnologies is trading 4.09% up today amid broader-market strength led by growth stocks

Adaptive Biotechnologies is trading at $29.51, up 4.09%, amid broader-market gains; no company-specific catalyst was identified for the move.

• On October 5, available coverage identified no new company-specific announcement; prior bullish analyst activity and clonoSEQ-related updates predate this session and do not establish today’s cause.
• The S&P 500 is up 0.67% and the Nasdaq 0.98%, with growth stocks leading; positive market sentiment is the clearest available context.
• No Adaptive Biotechnologies-specific volume information was available.